KUREvsGXCETF Comparison
ETF 1
KURE
KraneShares MSCI All China Health Care Index ETF
This fund is part of
China Blended Cap
+0.69%
VS
KraneShares MSCI All China Health Care Index ETF (KURE) and State Street SPDR S&P China ETF (GXC) belong to the same industry segment: China Blended Cap. KURE's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Non-Energy Materials. In contrast, GXC's top sector exposures are Technology, Finance and Consumer Non-Cyclicals. KURE is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.59% for GXC. KURE is up 0.17% year-to-date (YTD) with +$22M in YTD flows. GXC performs worse with -6.72% YTD performance, and +$14M in YTD flows. Run a side-by-side ETF comparison of KURE and GXC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
KURE vs GXC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/30/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | KURE GXC | +9.84%+4.84% | -0.46%-4.06% | +0.17%-6.72% | -10.50%-1.18% | -4.22%+21.46% | -47.23%-10.77% |
| Flows | KURE GXC | +$21M+$13M | +$17M+$13M | +$22M+$14M | -$896K+$28M | +$22M-$644M | -$25M-$588M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | KURE GXC | +31.73%+20.06% | +27.53%+19.00% | +26.47%+22.55% | +27.48%+24.98% |
| Max drawdown | KURE GXC | -16.96%-13.27% | -29.89%-19.17% | -31.17%-24.55% | -62.91%-48.72% |
| Max drawdown duration | KURE GXC | 68d84d | 325d301d | 619d423d | 1815d1787d |
Trading data
KURE | GXC | |
Last sale 7/31/2026 at 1:30 PM | $17.28 | $91.43 |
| Previous close 07/30/2026 | $17.27 | $91.08 |
| Consolidated volume 07/30/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
KURE | GXC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
KURE | GXC | |
|---|---|---|
| Last price | $17.28 | $91.43 |
| 1D performance | +0.06% | +0.38% |
| AuM | $98.82 M | $469.51 M |
| E/R | 0.79% | 0.59% |
Characteristics
KURE | GXC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | KraneShares | State Street Investment Management |
| Benchmark | MSCI China All Shares Health Care 10/40 Index | S&P China BMI Index |
| N° of holdings | 43 | 1141 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 31, 2018 | March 20, 2007 |
| ESG | No | No |
Advertisement
Exposure
Countries
KURE
China
86.22%
Switzerland
8.84%
Other
4.94%
GXC
China
88.17%
Other
11.83%
Sectors
KURE
Healthcare
98.15%
Other
1.85%
GXC
Technology
26.48%
Finance
19.04%
Consumer Non-Cycl.
12.73%
Industrials
9.92%
Non-Energy Materi.
8.2%
Other
23.62%
Diversification
KURE
Total weight of top 15 holdings out of 15
65.95%
GXC
Total weight of top 15 holdings out of 15
35.01%
Top 15 holdings
Data as of June 30, 2026
KURE
BeOne Medicines Ltd.
8.84%
Innovent Biologics, Inc.
8.80%
WuXi Biologics (Cayman), Inc.
7.51%
WuXi AppTec Co., Ltd.
5.79%
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
4.59%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
4.27%
Akeso, Inc.
3.72%
CSPC Pharmaceutical Group Ltd.
3.68%
Sino Biopharmaceutical Ltd.
3.39%
WuXi AppTec Co., Ltd.
3.35%
Hansoh Pharmaceutical Group Co., Ltd.
2.85%
3SBio, Inc.
2.49%
Yunnan Baiyao Group Co., Ltd.
2.30%
Shanghai United Imaging Healthcare Co., Ltd.
2.27%
Aier Eye Hospital Group Co., Ltd.
2.10%
GXC
Tencent Holdings Ltd.
9.92%
Alibaba Group Holding Ltd.
6.76%
China Construction Bank Corp.
3.07%
Industrial & Commercial Bank of China Ltd.
1.92%
PDD Holdings, Inc.
1.78%
Bank of China Ltd.
1.53%
Meituan
1.47%
Xiaomi Corp.
1.43%
NetEase, Inc.
1.34%
Ping An Insurance (Group) Co. of China Ltd.
1.27%
JD.com, Inc.
1.06%
BYD Co., Ltd.
1.02%
Baidu, Inc.
0.96%
China Life Insurance Co. Ltd.
0.78%
Contemporary Amperex Technology Co., Ltd.
0.70%
Frequently asked questions about KURE and GXC
How have the KURE and GXC ETFs performed in 2026?
As of July 30, 2026, KURE is up 0.17% year-to-date (YTD), while GXC has lost -6.72%. That puts KURE better performer ahead so far this year.
Which ETF is attracting more investor money: KURE or GXC?
Year-to-date, the KURE ETF saw +$22M in flows, compared to +$14M for GXC.
Which ETF is more volatile: KURE or GXC?
Over the past year, KURE had a volatility of 27.53%, while GXC experienced 19%.
Which ETF is bigger: KURE or GXC?
As of July 30, 2026, KURE holds $98.82 M in assets under management (AUM), while GXC manages $469.51 M.
What sectors do the KURE and GXC ETFs invest in?
KURE leans toward sectors like Healthcare. Meanwhile, GXC focuses on Technology, Finance and Consumer Non-Cyclicals.
What are the top holdings of the KURE ETF and GXC ETF?
KURE top holdings include BeOne Medicines Ltd., Innovent Biologics, Inc. and WuXi Biologics (Cayman), Inc.. GXC holds in its top three: Tencent Holdings Ltd., Alibaba Group Holding Ltd. and China Construction Bank Corp..
Which ETF is more diversified: KURE or GXC?
KURE holds 45 securities with 65.95% of its assets in the top 15. GXC has 1204 securities and a top 15 weight of 35.01%.
Advertisement
Latest news about KURE & GXC
Advertisement
